In Vitro Diagnostics Business Outlook: Volume 1, Issue 6 - Coagulation Testing

A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:

• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage

Table of Contents
  • Market Analysis: Focus on Coagulation Testing
    • Overview of Diagnostics in Coagulation
    • Market Outlook
      • Major Product Activity
      • Laboratory vs. Point-of-Care Markets
    • Regional Market
    • Top Company Briefs
      • Roche
      • Sysmex
      • Werfen
  • Executive News Briefing
    • Bio-Techne Appoints New President of Protein Sciences Segment
    • Mainz BioMed Appoints New VP of Regulatory Affairs
    • Lifespin GmbH Secures Financing
    • Numares Appoints New Member to Supervisory Board
    • Predicine Appoints New CFO
  • Financial Highlights: Agilent, Myriad Genetics and OraSure Technologies
    • Agilent Reports ‘Record-Setting Performance’ in Fiscal 2021
    • Myriad Genetics Reports 15% Growth in Third Quarter 2021
    • OraSure Technologies Focuses on InteliSwab Growth for FY22
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Mergers and Acquisitions
    • Partnerships and Collaborations
  • Industry Watch
    • COVID-19 Update
  • Region Watch
    • Canada
    • France
    • Vietnam
  • Broad-based Company Announcements
    • Labcorp
    • Quidel
    • NGeneBio
Attachments
  • pdf - IVDBO - Vol 1. Issue 6.pdf